Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock
Covered in this story
What has happened since
- Oramed Pharmaceuticals is up 1.3% since this was published, 2 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ORMP yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Oramed Pharmaceuticals →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.